🦊/Investors

Kairos Venture Partners

Venture capital

Beverly Hills · 1 people tracked

Find your way into Kairos Venture Partners

Fox Verdict
Sign up to see your fit

Fund manager profile

Kairos Venture Partners is a venture fund manager based in Beverly Hills. SEC filings show 3 venture funds on record, most recently Kairos Venture Partners III, L.P. ($250M offering) filed December 2021.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

HQ
Beverly Hills, US
Founded
2017
Last 12 months
2 investments
Tracked investments
5

Team · 1 people

from public directories

What they invest in

from 4 of 5 portfolio companies

Biotech ×2Healthtech ×2Advanced Manufacturing ×1AgTech ×1Medical Devices ×1

HQs:United States×5

Investments · 5 tracked

founders shown can be your intro path

By year:2026 · 12025 · 12018 · 12017 · 12016 · 15 dated

Compelloncompellon.comJan 2018SEC filingmedium confidence

Rancho Santa Margarita, US

Mark Pollard(Executive Officer, Director)Kenneth Charhut(Executive Officer, Director)Nikolai Liachenko(Director)

BoardJerry Pellizzon(Director)

Board seatJames Demetriades· per SEC Form D · $2.3M raise · filed Feb 2018

Foldaxfoldax.comin𝕏Apr 2017SEC filingmedium confidence

Foldax develops heart valve replacement technology leveraging polymer expertise and biologic design.

Advanced ManufacturingBiotechHealthtechMedical DevicesSalt Lake City, US

Frank Maguire(Executive Officer, Director)

BoardKen Charhut(Director)George Wallace(Director)Morteza Gharib(Director)Mory Gharib(Director)

Board seatJames Demetriades· per SEC Form D · $9M raise · filed May 2017

Co-investorsAngel Physicians FundKairos Venture Investments, LlcMemorialCare Innovation Fund

Linnaeus Therapeuticslinnaeustx.cominFeb 2026SEC filingmedium confidence

Clinical-stage biotech company developing small molecule agents modulating cellular differentiation for cancer and pigmentation disorders.

BiotechHaddonfield, US

Patrick T. Mooney(Executive Officer)in

BoardTodd Thomson(Director)inMichael D. Poisel(Director)Chris Arendt(Director)

Board seatJames Demetriades· per SEC Form D · $10M raise · filed Apr 2026

Co-investorsKairos Venture Investments, LlcIA Global

Proviviprovivi.comin𝕏Sep 2025SEC filingmedium confidence

AgTechSanta Monica, US

Frances Arnold(Director)inPeter Meinhold(Executive Officer)inPedro Coelho(Executive Officer)inCorey Huck(Executive Officer, Director)in

BoardGANESH KISHORE(Director)inALAN BOYCE(Director)

Board seatJames Demetriades· per SEC Form D · $40M raise · filed Apr 2026

Co-investorsAliment CapitalKairos Venture Investments, LlcPontifax AgTechSpruce Capital PartnersVivo CapitalXeraya Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Gene Sciences

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Portfolio news

latest coverage across their companies
Trysignalbase

Provivi · trysignalbase.com · Jun 11, 2026

Frequently asked questions

How many investments has Kairos Venture Partners made?
Kairos Venture Partners has 5 tracked investments, including 2 dated in the last 24 months.
Where is Kairos Venture Partners located?
Kairos Venture Partners is headquartered in Beverly Hills, US.

Featured in lists